JP2008538779A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538779A5
JP2008538779A5 JP2008508135A JP2008508135A JP2008538779A5 JP 2008538779 A5 JP2008538779 A5 JP 2008538779A5 JP 2008508135 A JP2008508135 A JP 2008508135A JP 2008508135 A JP2008508135 A JP 2008508135A JP 2008538779 A5 JP2008538779 A5 JP 2008538779A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound
unsubstituted
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008508135A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538779A (ja
Filing date
Publication date
Priority claimed from GBGB0508314.2A external-priority patent/GB0508314D0/en
Application filed filed Critical
Publication of JP2008538779A publication Critical patent/JP2008538779A/ja
Publication of JP2008538779A5 publication Critical patent/JP2008538779A5/ja
Pending legal-status Critical Current

Links

JP2008508135A 2005-04-25 2006-04-24 アセチレン誘導体 Pending JP2008538779A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0508314.2A GB0508314D0 (en) 2005-04-25 2005-04-25 Organic compounds
PCT/EP2006/003768 WO2006114264A1 (en) 2005-04-25 2006-04-24 Acetylene derivatives

Publications (2)

Publication Number Publication Date
JP2008538779A JP2008538779A (ja) 2008-11-06
JP2008538779A5 true JP2008538779A5 (cg-RX-API-DMAC10.html) 2009-07-02

Family

ID=34640064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008508135A Pending JP2008538779A (ja) 2005-04-25 2006-04-24 アセチレン誘導体

Country Status (17)

Country Link
US (1) US20080194551A1 (cg-RX-API-DMAC10.html)
EP (1) EP1877367B1 (cg-RX-API-DMAC10.html)
JP (1) JP2008538779A (cg-RX-API-DMAC10.html)
KR (1) KR20080007334A (cg-RX-API-DMAC10.html)
CN (1) CN101163669A (cg-RX-API-DMAC10.html)
AT (1) ATE445593T1 (cg-RX-API-DMAC10.html)
AU (1) AU2006239549A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0609945A2 (cg-RX-API-DMAC10.html)
CA (1) CA2605267A1 (cg-RX-API-DMAC10.html)
DE (1) DE602006009789D1 (cg-RX-API-DMAC10.html)
ES (1) ES2335134T3 (cg-RX-API-DMAC10.html)
GB (1) GB0508314D0 (cg-RX-API-DMAC10.html)
MX (1) MX2007013226A (cg-RX-API-DMAC10.html)
PL (1) PL1877367T3 (cg-RX-API-DMAC10.html)
PT (1) PT1877367E (cg-RX-API-DMAC10.html)
RU (1) RU2007143509A (cg-RX-API-DMAC10.html)
WO (1) WO2006114264A1 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
PE20060437A1 (es) * 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) * 2004-07-14 2004-08-18 Novartis Ag Organic compounds
GB0503646D0 (en) * 2005-02-22 2005-03-30 Novartis Ag Organic compounds
GB0508319D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
GB0508318D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
GB0525673D0 (en) * 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
CN102762572A (zh) 2010-02-01 2012-10-31 诺瓦提斯公司 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
RU2741576C2 (ru) * 2014-10-24 2021-01-27 Лэндос Байофарма, Инк. Лекарственные средства на основе лантионинсинтетаза c-подобного белка 2
US11197891B2 (en) 2017-11-30 2021-12-14 Landos Biopharma, Inc. Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
AU2020407645B2 (en) 2019-12-20 2022-10-06 Nimmune Biopharma, Inc. Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991064A (en) * 1975-01-17 1976-11-09 Warner-Lambert Company Benzonaphthyridines
US5576336A (en) * 1993-03-18 1996-11-19 Merck Sharp & Dohme Limited Indole derivatives as dopamine D4 antagonists
EP0689535B1 (en) * 1993-03-18 1998-09-23 MERCK SHARP & DOHME LTD. Benzimidazole derivatives
US5521297A (en) * 1993-06-04 1996-05-28 Salk Institute Biotechnology/Industrial Associates Nucleic acids encoding human metabotropic glutamate receptors
EP0757686A1 (en) * 1994-04-28 1997-02-12 MERCK SHARP & DOHME LTD. Benzofuran derivatives as d 4? receptor antagonists
AU699196B2 (en) * 1994-08-10 1998-11-26 Merck Sharp & Dohme Limited Tetrahydropyridinylmethyl derivatives of pyrrolo 2,3-b pyridine
US5688798A (en) * 1995-10-10 1997-11-18 Hoffmann-La Roche Inc. Pyrimidine compounds
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
GB0128996D0 (en) * 2001-12-04 2002-01-23 Novartis Ag Organic compounds
US6806279B2 (en) * 2001-12-17 2004-10-19 Sunesis Pharmaceuticals, Inc. Small-molecule inhibitors of interleukin-2
US6995144B2 (en) * 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
GB0503646D0 (en) * 2005-02-22 2005-03-30 Novartis Ag Organic compounds
GB0508319D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
GB0508318D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2008538775A5 (cg-RX-API-DMAC10.html)
US9255106B2 (en) Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors
JP6397488B2 (ja) RORγ調節因子
EP2253625B1 (en) Pyridazinones, the preparation and the use thereof
TWI771272B (zh) 克立咪唑(clemizole)化合物於預防及治療肝癌之用途
JP2010505930A5 (cg-RX-API-DMAC10.html)
CN108727378A (zh) 新型异喹啉类化合物及其医药用途
JP2022519237A (ja) Dnaポリメラーゼシータ阻害剤としてのアセトアミド誘導体
JP2014524476A5 (cg-RX-API-DMAC10.html)
US20240287098A1 (en) Compositions and methods for treating cancer
US20190092789A1 (en) Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
PT1877365E (pt) Derivados de acetileno
WO2001021206A1 (en) PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-λB INHIBITORS AS THE ACTIVE INGREDIENT
JP2007518767A5 (cg-RX-API-DMAC10.html)
CN1268122A (zh) 用作nos抑制剂的支化烷氧基取代的2-氨基吡啶
JP2014511865A (ja) 水溶液中で多量化できるシリル単量体、およびその使用法
JP6542236B2 (ja) 有機化合物
JPH11189586A (ja) キノリン誘導体、イソキノリン誘導体、およびシンノリン誘導体、並びに抗炎症剤および抗アレルギー剤
JP2005517634A5 (cg-RX-API-DMAC10.html)
EP4545525A1 (en) Novel compound and use thereof for treatment of autoimmune diseases
US20170369417A1 (en) TAK1 Kinase Inhibitors, Compositions, and Uses Related Thereto
JP2019504827A (ja) ポリヒドロキシ化ベンゾフェノンの組成物及び神経変性障害の処置方法
KR101965348B1 (ko) N'-히드록시인다졸카르복시이미다미드 유도체 화합물, 이의 광학이성질체, 또는 이의 약학적으로 허용가능한 염, 및, 이를 유효성분으로 포함하는 항암용 조성물
US9796722B1 (en) Hepatitis B viral assembly effectors
KR100816798B1 (ko) 의약용 트리에틸렌테트라민 이염산염의 제조방법